Antiarthritic Effects of Glucosamine Sulfate Studied in Animal Models
 
   

Antiarthritic Effects of Glucosamine Sulfate
Studied in Animal Models

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:
   Frankp@chiro.org
 
   

FROM: Arzneimittel–Forschung/Drug Research 1991 (May);   41 (5):   542-545

Setnikar I, Pacini MA, Revel L


Rotta Research Laboratorium S.p.A., Monza, Italy

The antireactive activity of glucosamine sulfate (GS) (CAS 29031-19-4) was tested in the rat in experimental models of subacute inflammation (sponge granuloma and croton oil granuloma), on subacute mechanical arthritis (kaolin arthritis) and in immunological-reactive arthritis and generalized inflammation (adjuvant arthritis). On these models GS was found effective in oral daily doses of 50-800 mg/kg. Tne potency of GS in comparison of that of indometacin used in the same tests as reference substance was found 50-300 times lower. Since, however, the toxicity of indometacin in chronic toxicity experiments is 1000-4000 times larger, the therapeutic margin with regard to prolonged treatments of inflammatory disorders results 10-30 times more favourable for GS than for indometacin. GS can therefore be considered as a drug of choice for prolonged oral treatment of rheumatic disorders.



Return to the GLUCOSAMINE Page

Since 4-01-1998

             © 1995—2014    The Chiropractic Resource Organization    All Rights Reserved